US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Immutep Limited

2.62

0.0000

Post-market: 2.620.00000.00%16:10 EST

Volume:156.48K

Turnover:410.16K

Market Cap:385.64M

PE:-9.47

High:2.68

Open:2.65

Low:2.56

Close:2.62

52wk High:3.53

52wk Low:1.32

Shares:147.19M

Float Shares:122.82M

Volume Ratio:0.79

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2767

EPS(LYR):-0.2767

ROE:-36.88%

ROA:-22.66%

PB:3.83

PE(LYR):-9.47

Loading ...

Overview Company News Filings

Immutep Hits 50% Enrollment in Late-Stage Lung Cancer Trial Combining Efti With Keytruda and Chemotherapy

MT Newswires Live

Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC

Immutep reports Q2 cash receipts from customers A$4,000

Why Wall Street Is Watching Immutep's Experimental Autoimmune Treatment Closely

Immutep Announces Positive Update on IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases, from Phase I Study

Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace

Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa

Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium

Translational Data and Significant Pathologic Response Rates from EFTISARC-NEO Phase II Highlighted in Oral Presentation at CTOS 2025

Immutep Receives A$4.6 million R&D Tax Incentive from French Government

Immutep Quarterly Activities Report Q1 FY26

Immutep Limited Releases 2025 Corporate Governance Statement

Immutep Says its Mid-Stage Trial of Eftilagimod Alfa Meets Primary Endpoint of Tumor Hyalinization/Fibrosis

MT Newswires Live

Immutep announces Phase II study of eftilagimod alfa met primary endpoint

Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress 2025

Two Posters at ESMO Congress 2025 Highlight Immutep’s Focus on Changing Treatment Landscape in First Line Non-Small Cell Lung Cancer

Immutep announces update for TACTI-004 Phase III trial

Immutep Announces Research Collaboration with the George Washington University Cancer Center to Evaluate Neoadjuvant Efti

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IMMP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMMP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMMP\",,,,,undefined,":{"symbol":"IMMP","market":"US","secType":"STK","nameCN":"Immutep Limited","latestPrice":2.62,"timestamp":1770411600000,"preClose":2.62,"halted":0,"volume":156478,"hourTrading":{"tag":"盘后","latestPrice":2.62,"preClose":2.62,"latestTime":"16:10 EST","volume":8,"amount":20.94,"timestamp":1770412204845,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0,"floatShares":122824715,"shares":147192033,"eps":-0.27666,"marketStatus":"Market Closed","change":0,"latestTime":"02-06 16:00:00 EST","open":2.65,"high":2.675,"low":2.56,"amount":410156.4392,"amplitude":0.043893,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.27666,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":10,"exchange":"NASDAQ","adjPreClose":2.62,"preHourTrading":{"tag":"盘前","latestPrice":2.69,"preClose":2.62,"latestTime":"09:28 EST","volume":807,"amount":2189.4298974,"timestamp":1770388080111,"change":0.07,"changeRate":0.026718,"amplitude":0.041985},"postHourTrading":{"tag":"盘后","latestPrice":2.62,"preClose":2.62,"latestTime":"16:10 EST","volume":8,"amount":20.94,"timestamp":1770412204845,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7864828565890689,"impliedVol":0.5252,"impliedVolPercentile":0.012},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMMP\",,,,,undefined,":{"symbol":"IMMP","floatShares":122824715,"roa":"-22.66%","roe":"-36.88%","lyrEps":-0.27666,"volumeRatio":0.7864828565890689,"shares":147192033,"dividePrice":0,"high":2.675,"amplitude":0.043893,"preClose":2.62,"low":2.56,"week52Low":1.32,"pbRate":"3.83","psRate":"109.01","week52High":3.5299,"institutionHeld":0,"latestPrice":2.62,"eps":-0.27666,"divideRate":0,"volume":156478,"delay":0,"ttmEps":-0.27666,"open":2.65,"prevYearClose":2.86,"prevWeekClose":2.73,"prevMonthClose":2.73,"prevQuarterClose":2.86,"fiveDayClose":2.73,"twentyDayClose":2.98,"sixtyDayClose":1.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMMP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-28","symbol":"IMMP","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1756353600000,"reportTimeType":"post","actualEps":null},{"date":"2025-04-28","symbol":"IMMP","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1745870400000,"name":null,"time":"Post Market","dateTimestamp":1745812800000,"actualEps":null},{"date":"2025-02-26","symbol":"IMMP","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740560400000,"name":null,"time":"","dateTimestamp":1740546000000,"actualEps":null},{"market":"US","date":"2024-08-29","symbol":"IMMP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724904000000,"reportTimeType":"post","actualEps":null},{"date":"2024-07-31","symbol":"IMMP","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722412800000,"name":null,"time":"","dateTimestamp":1722398400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMMP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMMP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1715922000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMMP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMMP","date":"2026-02-06","current":-9.470108,"percent":0.698864,"low":-21.193511,"twenty":-12.726034,"median":-10.280337,"eighty":-8.052951,"high":-5.410848,"avg":-10.447529,"sd":2.834588,"marketCap":374666208.82},"quantilePoints":[{"date":"2021-02-12","current":-19.989334,"twenty":-8.49482,"median":-5.98097,"eighty":-4.426035,"marketCap":208795558.4},{"date":"2021-02-19","current":-19.266828,"twenty":-8.501234,"median":-5.98097,"eighty":-4.426035,"marketCap":204242513.97},{"date":"2021-02-26","current":-8.061046,"twenty":-8.546901,"median":-5.98097,"eighty":-4.426035,"marketCap":170164015.58},{"date":"2021-03-05","current":-7.349777,"twenty":-8.568063,"median":-6.020775,"eighty":-4.426035,"marketCap":153938179.73},{"date":"2021-03-12","current":-7.942501,"twenty":-8.568063,"median":-6.020775,"eighty":-4.426035,"marketCap":168611195.59},{"date":"2021-03-19","current":-8.969039,"twenty":-8.652879,"median":-6.020775,"eighty":-4.426035,"marketCap":190108566.89},{"date":"2021-03-26","current":-11.303447,"twenty":-8.714025,"median":-6.020775,"eighty":-4.426035,"marketCap":235915548.44},{"date":"2021-04-01","current":-10.320538,"twenty":-8.783086,"median":-6.020775,"eighty":-4.426035,"marketCap":214729610.68},{"date":"2021-04-09","current":-11.180583,"twenty":-8.870472,"median":-6.020775,"eighty":-4.426035,"marketCap":233208939.62},{"date":"2021-04-16","current":-10.811993,"twenty":-8.946901,"median":-6.084546,"eighty":-4.426035,"marketCap":228746692.96},{"date":"2021-04-23","current":-10.443402,"twenty":-8.965754,"median":-6.089205,"eighty":-4.426035,"marketCap":221051062.12},{"date":"2021-04-30","current":-11.303447,"twenty":-9.015941,"median":-6.089205,"eighty":-4.426035,"marketCap":238315059.33},{"date":"2021-05-07","current":-10.443402,"twenty":-9.067662,"median":-6.089205,"eighty":-4.426035,"marketCap":224242884.72},{"date":"2021-05-14","current":-11.320767,"twenty":-9.113322,"median":-6.089205,"eighty":-4.426035,"marketCap":240814114.13},{"date":"2021-05-21","current":-15.391155,"twenty":-9.16286,"median":-6.089205,"eighty":-4.426035,"marketCap":325752852.72},{"date":"2021-05-28","current":-16.408752,"twenty":-9.232532,"median":-6.089205,"eighty":-4.426035,"marketCap":345898929.89},{"date":"2021-06-04","current":-16.91755,"twenty":-9.300238,"median":-6.089205,"eighty":-4.426035,"marketCap":358363840.68},{"date":"2021-06-11","current":-17.277191,"twenty":-9.413093,"median":-6.089205,"eighty":-4.426035,"marketCap":363757362.27},{"date":"2021-06-18","current":-16.222095,"twenty":-9.427574,"median":-6.089205,"eighty":-4.426035,"marketCap":332237654.94},{"date":"2021-06-25","current":-14.243791,"twenty":-9.498107,"median":-6.089205,"eighty":-4.426035,"marketCap":296176821.19},{"date":"2021-07-02","current":-14.901793,"twenty":-9.514678,"median":-6.089205,"eighty":-4.426035,"marketCap":305700516.57},{"date":"2021-07-09","current":-14.081511,"twenty":-9.672327,"median":-6.089205,"eighty":-4.426035,"marketCap":288073840},{"date":"2021-07-16","current":-13.808083,"twenty":-9.733971,"median":-6.089205,"eighty":-4.426035,"marketCap":279843887.12},{"date":"2021-07-23","current":-13.923528,"twenty":-9.757434,"median":-6.089205,"eighty":-4.426035,"marketCap":280790125.29},{"date":"2021-07-30","current":-14.927361,"twenty":-9.892023,"median":-6.089205,"eighty":-4.426035,"marketCap":300060934.47},{"date":"2021-08-06","current":-15.860321,"twenty":-9.926249,"median":-6.089205,"eighty":-4.426035,"marketCap":319025676.69},{"date":"2021-08-13","current":-15.393841,"twenty":-10.056079,"median":-6.129342,"eighty":-4.426035,"marketCap":310693210.89},{"date":"2021-08-20","current":-13.683414,"twenty":-10.098481,"median":-6.147393,"eighty":-4.426035,"marketCap":267013287.69},{"date":"2021-08-27","current":-16.171308,"twenty":-10.202125,"median":-6.147393,"eighty":-4.426035,"marketCap":322742418.67},{"date":"2021-09-03","current":-16.647029,"twenty":-10.370332,"median":-6.147393,"eighty":-4.52787,"marketCap":370517184.96},{"date":"2021-09-10","current":-15.935617,"twenty":-10.370332,"median":-6.191293,"eighty":-4.531417,"marketCap":351128706.8},{"date":"2021-09-17","current":-15.081923,"twenty":-10.379194,"median":-6.229135,"eighty":-4.55787,"marketCap":327992061.09},{"date":"2021-09-24","current":-15.224206,"twenty":-10.443402,"median":-6.245338,"eighty":-4.604765,"marketCap":329910644.25},{"date":"2021-10-01","current":-15.651053,"twenty":-10.566265,"median":-6.250192,"eighty":-4.636799,"marketCap":339702068.67},{"date":"2021-10-08","current":-15.224206,"twenty":-10.612525,"median":-6.298039,"eighty":-4.636799,"marketCap":332902155.76},{"date":"2021-10-15","current":-15.366488,"twenty":-10.634174,"median":-6.340698,"eighty":-4.665122,"marketCap":341051222.44},{"date":"2021-10-22","current":-17.216158,"twenty":-10.68401,"median":-6.404785,"eighty":-4.684004,"marketCap":384644571.13},{"date":"2021-10-29","current":-16.220182,"twenty":-10.684584,"median":-6.447964,"eighty":-4.74813,"marketCap":363996995.12},{"date":"2021-11-05","current":-18.923545,"twenty":-10.684584,"median":-6.509916,"eighty":-4.795212,"marketCap":418972058.34},{"date":"2021-11-12","current":-17.35844,"twenty":-10.684584,"median":-6.509916,"eighty":-4.840137,"marketCap":380126626.14},{"date":"2021-11-19","current":-15.366488,"twenty":-10.7955,"median":-6.529904,"eighty":-4.840137,"marketCap":333428860.02},{"date":"2021-11-26","current":-13.943665,"twenty":-10.837539,"median":-6.529904,"eighty":-4.840137,"marketCap":296784235.18},{"date":"2021-12-03","current":-13.282015,"twenty":-10.899458,"median":-6.686777,"eighty":-4.847562,"marketCap":278850735.1},{"date":"2021-12-10","current":-13.710467,"twenty":-10.998837,"median":-6.72778,"eighty":-4.863911,"marketCap":293997091.43},{"date":"2021-12-17","current":-13.282015,"twenty":-11.05772,"median":-6.743268,"eighty":-4.954207,"marketCap":284238962.28},{"date":"2021-12-23","current":-14.138919,"twenty":-11.117545,"median":-6.743268,"eighty":-4.974231,"marketCap":305771885.44},{"date":"2021-12-31","current":-13.996102,"twenty":-11.180586,"median":-6.792956,"eighty":-4.974231,"marketCap":304311911.58},{"date":"2022-01-07","current":-13.56765,"twenty":-11.313089,"median":-6.850822,"eighty":-4.993174,"marketCap":290934621.73},{"date":"2022-01-14","current":-12.99638,"twenty":-11.313089,"median":-6.925591,"eighty":-5.041602,"marketCap":280778754.43},{"date":"2022-01-21","current":-11.996659,"twenty":-11.401956,"median":-6.925656,"eighty":-5.048232,"marketCap":258470765.91},{"date":"2022-01-28","current":-10.425668,"twenty":-11.425573,"median":-6.984099,"eighty":-5.048232,"marketCap":218040860.26},{"date":"2022-02-04","current":-11.139755,"twenty":-11.468208,"median":-7.060172,"eighty":-5.048232,"marketCap":235312158.8},{"date":"2022-02-11","current":-11.139755,"twenty":-11.468208,"median":-7.075996,"eighty":-5.048232,"marketCap":239009752.46},{"date":"2022-02-18","current":-10.568485,"twenty":-11.468208,"median":-7.135535,"eighty":-5.083919,"marketCap":226834220.5},{"date":"2022-02-25","current":-11.029859,"twenty":-11.523012,"median":-7.15201,"eighty":-5.149849,"marketCap":209782382.43},{"date":"2022-03-04","current":-11.678674,"twenty":-11.552981,"median":-7.22493,"eighty":-5.152375,"marketCap":225925207.94},{"date":"2022-03-11","current":-12.165286,"twenty":-11.627342,"median":-7.227807,"eighty":-5.152375,"marketCap":234100314.28},{"date":"2022-03-18","current":-12.814101,"twenty":-11.678674,"median":-7.227807,"eighty":-5.152404,"marketCap":249761997.33},{"date":"2022-03-25","current":-13.300712,"twenty":-11.941594,"median":-7.309932,"eighty":-5.161447,"marketCap":262866197.27},{"date":"2022-04-01","current":-12.32749,"twenty":-12.122055,"median":-7.354406,"eighty":-5.189834,"marketCap":243248642.73},{"date":"2022-04-08","current":-11.678674,"twenty":-12.165286,"median":-7.449364,"eighty":-5.26909,"marketCap":229209249.35},{"date":"2022-04-14","current":-11.192063,"twenty":-12.165286,"median":-7.497988,"eighty":-5.287682,"marketCap":218324343.19},{"date":"2022-04-22","current":-10.543248,"twenty":-12.165286,"median":-7.54206,"eighty":-5.288624,"marketCap":201590348.58},{"date":"2022-04-29","current":-11.029859,"twenty":-12.165286,"median":-7.625697,"eighty":-5.298707,"marketCap":206090236.32},{"date":"2022-05-06","current":-11.354267,"twenty":-12.165286,"median":-7.698431,"eighty":-5.342649,"marketCap":212619473.68},{"date":"2022-05-13","current":-11.192063,"twenty":-12.165286,"median":-7.725164,"eighty":-5.342649,"marketCap":203883184.11},{"date":"2022-05-20","current":-12.814101,"twenty":-12.32749,"median":-7.784292,"eighty":-5.350543,"marketCap":237072943.57},{"date":"2022-05-27","current":-12.814101,"twenty":-12.378557,"median":-7.843737,"eighty":-5.380507,"marketCap":241346667.14},{"date":"2022-06-03","current":-13.949528,"twenty":-12.562743,"median":-7.856312,"eighty":-5.464671,"marketCap":265006713.33},{"date":"2022-06-10","current":-12.003082,"twenty":-12.570241,"median":-7.942501,"eighty":-5.49271,"marketCap":222725657.9},{"date":"2022-06-17","current":-10.056636,"twenty":-12.570241,"median":-7.963894,"eighty":-5.495272,"marketCap":183250098.97},{"date":"2022-06-24","current":-10.381044,"twenty":-12.572553,"median":-7.963894,"eighty":-5.495272,"marketCap":189963369.47},{"date":"2022-07-01","current":-10.056636,"twenty":-12.572553,"median":-7.963894,"eighty":-5.521672,"marketCap":179729885.96},{"date":"2022-07-08","current":-10.543248,"twenty":-12.572553,"median":-7.985728,"eighty":-5.521672,"marketCap":190600048.06},{"date":"2022-07-15","current":-10.692819,"twenty":-12.572553,"median":-8.072073,"eighty":-5.521672,"marketCap":191528633.92},{"date":"2022-07-22","current":-10.692819,"twenty":-12.572553,"median":-8.072073,"eighty":-5.529016,"marketCap":195722983.18},{"date":"2022-07-29","current":-11.186334,"twenty":-12.572553,"median":-8.219475,"eighty":-5.535074,"marketCap":205484920.81},{"date":"2022-08-05","current":-10.692819,"twenty":-12.572553,"median":-8.229357,"eighty":-5.53996,"marketCap":194076891.63},{"date":"2022-08-12","current":-10.857324,"twenty":-12.572553,"median":-8.229357,"eighty":-5.540524,"marketCap":203039376.38},{"date":"2022-08-19","current":-10.199305,"twenty":-12.572553,"median":-8.309487,"eighty":-5.540524,"marketCap":184394933.74},{"date":"2022-08-26","current":-9.870295,"twenty":-12.572553,"median":-8.484817,"eighty":-5.540524,"marketCap":179941797.53},{"date":"2022-09-02","current":-7.529988,"twenty":-12.572553,"median":-8.49482,"eighty":-5.604113,"marketCap":165934971.61},{"date":"2022-09-09","current":-7.26106,"twenty":-12.572553,"median":-8.49482,"eighty":-5.620805,"marketCap":160008722.72},{"date":"2022-09-16","current":-7.529988,"twenty":-12.572553,"median":-8.49482,"eighty":-5.620805,"marketCap":162456227.73},{"date":"2022-09-23","current":-6.992132,"twenty":-12.572553,"median":-8.49482,"eighty":-5.635111,"marketCap":147406473.59},{"date":"2022-09-30","current":-6.58874,"twenty":-12.572553,"median":-8.49482,"eighty":-5.635111,"marketCap":136727711.64},{"date":"2022-10-07","current":-7.31724,"twenty":-12.572553,"median":-8.49482,"eighty":-5.635111,"marketCap":150757544.45},{"date":"2022-10-14","current":-7.723753,"twenty":-12.572553,"median":-8.49482,"eighty":-5.635111,"marketCap":154960122.08},{"date":"2022-10-21","current":-7.914604,"twenty":-12.572553,"median":-8.49482,"eighty":-5.635111,"marketCap":161402938.27},{"date":"2022-10-28","current":-7.641687,"twenty":-12.572553,"median":-8.49482,"eighty":-5.635111,"marketCap":157552996.22},{"date":"2022-11-04","current":-8.596898,"twenty":-12.572553,"median":-8.49482,"eighty":-5.635111,"marketCap":178526966.02},{"date":"2022-11-11","current":-8.596898,"twenty":-12.572553,"median":-8.535225,"eighty":-5.635111,"marketCap":185250988.09},{"date":"2022-11-18","current":-8.32398,"twenty":-12.572553,"median":-8.546901,"eighty":-5.635111,"marketCap":179286046.81},{"date":"2022-11-25","current":-8.869815,"twenty":-12.572553,"median":-8.546901,"eighty":-5.635111,"marketCap":192717755.14},{"date":"2022-12-02","current":-9.825026,"twenty":-12.572553,"median":-8.596898,"eighty":-5.64858,"marketCap":214644738.88},{"date":"2022-12-09","current":-9.41565,"twenty":-12.572553,"median":-8.65377,"eighty":-5.64858,"marketCap":206373068.18},{"date":"2022-12-16","current":-8.596898,"twenty":-12.572553,"median":-8.711703,"eighty":-5.65756,"marketCap":185263381.95},{"date":"2022-12-23","current":-7.77997,"twenty":-12.572553,"median":-8.711703,"eighty":-5.706629,"marketCap":167995745.12},{"date":"2022-12-30","current":-7.506988,"twenty":-12.572553,"median":-8.711703,"eighty":-5.730805,"marketCap":164348737.17},{"date":"2023-01-06","current":-8.189442,"twenty":-12.572553,"median":-8.711703,"eighty":-5.730805,"marketCap":180528803.04},{"date":"2023-01-13","current":-8.052951,"twenty":-12.572553,"median":-8.711703,"eighty":-5.730805,"marketCap":180409103.49},{"date":"2023-01-20","current":-8.189442,"twenty":-12.572553,"median":-8.711703,"eighty":-5.730805,"marketCap":183492408.88},{"date":"2023-01-27","current":-7.77997,"twenty":-12.572553,"median":-8.711703,"eighty":-5.730805,"marketCap":178121581.49},{"date":"2023-02-03","current":-7.77997,"twenty":-12.572553,"median":-8.711703,"eighty":-5.730805,"marketCap":174512014.62},{"date":"2023-02-10","current":-7.370498,"twenty":-12.572553,"median":-8.711703,"eighty":-5.7384,"marketCap":164251984.92},{"date":"2023-02-17","current":-6.961026,"twenty":-12.572553,"median":-8.711703,"eighty":-5.7384,"marketCap":153617692.52},{"date":"2023-02-24","current":-5.891813,"twenty":-12.572553,"median":-8.711703,"eighty":-5.7384,"marketCap":145068975.08},{"date":"2023-03-03","current":-5.891813,"twenty":-12.572553,"median":-8.711703,"eighty":-5.771572,"marketCap":145421512.08},{"date":"2023-03-10","current":-6.372777,"twenty":-12.572553,"median":-8.711703,"eighty":-5.776938,"marketCap":154293034.04},{"date":"2023-03-17","current":-6.7335,"twenty":-12.572553,"median":-8.711703,"eighty":-5.776938,"marketCap":164860569.84},{"date":"2023-03-24","current":-6.613259,"twenty":-12.572553,"median":-8.711703,"eighty":-5.776938,"marketCap":160551289.42},{"date":"2023-03-31","current":-6.252536,"twenty":-12.570241,"median":-8.711703,"eighty":-5.776938,"marketCap":153300383.56},{"date":"2023-04-06","current":-5.65133,"twenty":-12.570241,"median":-8.711703,"eighty":-5.771572,"marketCap":137719589.44},{"date":"2023-04-14","current":-5.891813,"twenty":-12.572553,"median":-8.711703,"eighty":-5.771572,"marketCap":145904116.49},{"date":"2023-04-21","current":-6.132295,"twenty":-12.572553,"median":-8.711703,"eighty":-5.771572,"marketCap":151459324.51},{"date":"2023-04-28","current":-6.372777,"twenty":-12.572553,"median":-8.711703,"eighty":-5.771572,"marketCap":154313470.2},{"date":"2023-05-05","current":-6.132295,"twenty":-12.572553,"median":-8.711703,"eighty":-5.771572,"marketCap":149490222.01},{"date":"2023-05-12","current":-5.531089,"twenty":-12.572553,"median":-8.711703,"eighty":-5.7384,"marketCap":135375857.15},{"date":"2023-05-19","current":-8.416875,"twenty":-12.572553,"median":-8.711703,"eighty":-5.7384,"marketCap":203513734.29},{"date":"2023-05-26","current":-7.575188,"twenty":-12.572553,"median":-8.652285,"eighty":-5.7384,"marketCap":180218701.28},{"date":"2023-06-02","current":-6.252536,"twenty":-12.572553,"median":-8.596898,"eighty":-5.7384,"marketCap":150158858.46},{"date":"2023-06-09","current":-9.042987,"twenty":-12.564039,"median":-8.596898,"eighty":-5.7384,"marketCap":222044547.04},{"date":"2023-06-16","current":-9.354814,"twenty":-12.564039,"median":-8.596898,"eighty":-5.7384,"marketCap":234987729.46},{"date":"2023-06-23","current":-8.73116,"twenty":-12.565336,"median":-8.596898,"eighty":-5.7384,"marketCap":215458547.61},{"date":"2023-06-30","current":-9.822555,"twenty":-12.565336,"median":-8.596898,"eighty":-5.7384,"marketCap":238210881.48},{"date":"2023-07-07","current":-10.066358,"twenty":-12.565336,"median":-8.596898,"eighty":-5.7384,"marketCap":243332621.98},{"date":"2023-07-14","current":-10.391079,"twenty":-12.565336,"median":-8.596898,"eighty":-5.7384,"marketCap":261395243.21},{"date":"2023-07-21","current":-10.55344,"twenty":-12.565336,"median":-8.596898,"eighty":-5.7384,"marketCap":261769565.84},{"date":"2023-07-28","current":-10.066358,"twenty":-12.565336,"median":-8.596898,"eighty":-5.7384,"marketCap":247988764.32},{"date":"2023-08-04","current":-10.066358,"twenty":-12.565336,"median":-8.596898,"eighty":-5.7384,"marketCap":241259126.9},{"date":"2023-08-11","current":-9.579276,"twenty":-12.565336,"median":-8.596898,"eighty":-5.7384,"marketCap":229690688.57},{"date":"2023-08-18","current":-9.092194,"twenty":-12.565336,"median":-8.596898,"eighty":-5.7384,"marketCap":213283978.96},{"date":"2023-08-25","current":-8.929833,"twenty":-12.565336,"median":-8.599805,"eighty":-5.7384,"marketCap":209865797.02},{"date":"2023-09-01","current":-8.481535,"twenty":-12.565336,"median":-8.602459,"eighty":-5.7384,"marketCap":219088552.28},{"date":"2023-09-08","current":-8.779133,"twenty":-12.565336,"median":-8.602459,"eighty":-5.7384,"marketCap":223163638.74},{"date":"2023-09-15","current":-9.225529,"twenty":-12.565336,"median":-8.599805,"eighty":-5.7384,"marketCap":237155234.54},{"date":"2023-09-22","current":-8.927931,"twenty":-12.565336,"median":-8.599805,"eighty":-5.7384,"marketCap":228753363.3},{"date":"2023-09-29","current":-8.332736,"twenty":-12.565336,"median":-8.598351,"eighty":-5.7384,"marketCap":213201909.83},{"date":"2023-10-06","current":-7.896491,"twenty":-12.489693,"median":-8.596898,"eighty":-5.7384,"marketCap":199962651.86},{"date":"2023-10-13","current":-7.896491,"twenty":-12.489693,"median":-8.531057,"eighty":-5.7384,"marketCap":199494147.67},{"date":"2023-10-20","current":-8.194472,"twenty":-12.489693,"median":-8.49482,"eighty":-5.7384,"marketCap":206695013.59},{"date":"2023-10-27","current":-9.386395,"twenty":-12.489693,"median":-8.49482,"eighty":-5.7384,"marketCap":236088063.3},{"date":"2023-11-03","current":-8.939424,"twenty":-12.489693,"median":-8.49482,"eighty":-5.7384,"marketCap":228856755.01},{"date":"2023-11-10","current":-8.492453,"twenty":-12.489693,"median":-8.492453,"eighty":-5.7384,"marketCap":217567487.96},{"date":"2023-11-17","current":-8.790434,"twenty":-12.489693,"median":-8.492453,"eighty":-5.7384,"marketCap":226656882.31},{"date":"2023-11-24","current":-8.939424,"twenty":-12.489693,"median":-8.492453,"eighty":-5.7384,"marketCap":234007195.72},{"date":"2023-12-01","current":-8.939424,"twenty":-12.489693,"median":-8.492453,"eighty":-5.7384,"marketCap":236176655.19},{"date":"2023-12-08","current":-9.237405,"twenty":-12.489693,"median":-8.492453,"eighty":-5.7384,"marketCap":242971197.92},{"date":"2023-12-15","current":-9.535385,"twenty":-12.489693,"median":-8.49482,"eighty":-5.7384,"marketCap":255268776.76},{"date":"2023-12-22","current":-10.280337,"twenty":-12.489693,"median":-8.53678,"eighty":-5.7384,"marketCap":278670962.09},{"date":"2023-12-29","current":-10.280337,"twenty":-12.489693,"median":-8.596898,"eighty":-5.7384,"marketCap":280846290.06},{"date":"2024-01-05","current":-10.280337,"twenty":-12.489693,"median":-8.596898,"eighty":-5.7384,"marketCap":275322495.8},{"date":"2024-01-12","current":-11.32327,"twenty":-12.489693,"median":-8.599805,"eighty":-5.7384,"marketCap":300630286.82},{"date":"2024-01-19","current":-10.727309,"twenty":-12.489693,"median":-8.630334,"eighty":-5.7384,"marketCap":280882352.83},{"date":"2024-01-26","current":-9.982357,"twenty":-12.489693,"median":-8.641443,"eighty":-5.7384,"marketCap":262237161.39},{"date":"2024-02-02","current":-9.982357,"twenty":-12.489693,"median":-8.655563,"eighty":-5.7384,"marketCap":261051112.35},{"date":"2024-02-09","current":-10.876299,"twenty":-12.489693,"median":-8.73116,"eighty":-5.7384,"marketCap":281276083.49},{"date":"2024-02-16","current":-10.131347,"twenty":-12.489693,"median":-8.769894,"eighty":-5.7384,"marketCap":263033610.98},{"date":"2024-02-23","current":-10.280337,"twenty":-12.489693,"median":-8.779133,"eighty":-5.7384,"marketCap":268316055.21},{"date":"2024-03-01","current":-10.273552,"twenty":-12.489693,"median":-8.790434,"eighty":-5.7384,"marketCap":270593805.68},{"date":"2024-03-08","current":-12.034732,"twenty":-12.489693,"median":-8.790434,"eighty":-5.7384,"marketCap":322838898.53},{"date":"2024-03-15","current":-10.713847,"twenty":-12.489693,"median":-8.897839,"eighty":-5.7384,"marketCap":285890508.63},{"date":"2024-03-22","current":-11.300907,"twenty":-12.489693,"median":-8.929833,"eighty":-5.7384,"marketCap":300802645.24},{"date":"2024-03-28","current":-11.154142,"twenty":-12.489693,"median":-8.939424,"eighty":-5.7384,"marketCap":294745959.42},{"date":"2024-04-05","current":-11.887967,"twenty":-12.489693,"median":-8.965754,"eighty":-5.7384,"marketCap":318564242.42},{"date":"2024-04-12","current":-11.007377,"twenty":-12.489693,"median":-8.987656,"eighty":-5.7384,"marketCap":290280608.8},{"date":"2024-04-19","current":-10.420317,"twenty":-12.489693,"median":-9.047244,"eighty":-5.771572,"marketCap":271772984.74},{"date":"2024-04-26","current":-12.328262,"twenty":-12.570241,"median":-9.088414,"eighty":-5.775865,"marketCap":324775929.49},{"date":"2024-05-03","current":-12.768557,"twenty":-12.651897,"median":-9.091903,"eighty":-5.776938,"marketCap":338289417.81},{"date":"2024-05-10","current":-13.502383,"twenty":-12.776487,"median":-9.148728,"eighty":-5.812307,"marketCap":361347890.18},{"date":"2024-05-17","current":-13.355617,"twenty":-12.814101,"median":-9.1989,"eighty":-5.891813,"marketCap":361191055.02},{"date":"2024-05-24","current":-13.062087,"twenty":-12.848442,"median":-9.232532,"eighty":-5.891813,"marketCap":350421526.13},{"date":"2024-05-31","current":-13.208852,"twenty":-12.915322,"median":-9.237405,"eighty":-5.917985,"marketCap":355512726.61},{"date":"2024-06-07","current":-12.621792,"twenty":-12.976305,"median":-9.279262,"eighty":-5.917985,"marketCap":340526818.55},{"date":"2024-06-14","current":-14.420895,"twenty":-12.98032,"median":-9.354814,"eighty":-5.917985,"marketCap":387799515.97},{"date":"2024-06-21","current":-14.772625,"twenty":-13.046991,"median":-9.386395,"eighty":-5.933072,"marketCap":398289398.88},{"date":"2024-06-28","current":-10.37601,"twenty":-13.062087,"median":-9.406239,"eighty":-6.005203,"marketCap":279193318.5},{"date":"2024-07-05","current":-10.37601,"twenty":-13.062087,"median":-9.50558,"eighty":-6.084546,"marketCap":282724557.99},{"date":"2024-07-12","current":-12.486385,"twenty":-13.062087,"median":-9.514678,"eighty":-6.131704,"marketCap":342346796.64},{"date":"2024-07-15","current":-11.255333,"twenty":-13.062087,"median":-9.514678,"eighty":-6.132295,"marketCap":308970783.52},{"date":"2024-08-02","current":-11.958791,"twenty":-13.128431,"median":-9.568764,"eighty":-6.245338,"marketCap":315761432.95},{"date":"2024-08-09","current":-11.255333,"twenty":-13.128431,"median":-9.688567,"eighty":-6.252536,"marketCap":299550199.76},{"date":"2024-08-16","current":-12.486385,"twenty":-13.128431,"median":-9.741636,"eighty":-6.252536,"marketCap":335198971.3},{"date":"2024-08-23","current":-13.013979,"twenty":-13.128431,"median":-9.822555,"eighty":-6.306571,"marketCap":353651982.69},{"date":"2024-08-30","current":-13.506266,"twenty":-13.13906,"median":-9.870295,"eighty":-6.372777,"marketCap":391811279.46},{"date":"2024-09-06","current":-13.262255,"twenty":-13.201637,"median":-9.903909,"eighty":-6.379179,"marketCap":380673829.46},{"date":"2024-09-13","current":-13.602313,"twenty":-13.208852,"median":-9.978468,"eighty":-6.495257,"marketCap":389049157.01},{"date":"2024-09-20","current":-11.561966,"twenty":-13.208852,"median":-9.982357,"eighty":-6.593644,"marketCap":336275739.09},{"date":"2024-09-27","current":-11.561966,"twenty":-13.208852,"median":-10.0348,"eighty":-6.628216,"marketCap":340330883.41},{"date":"2024-10-04","current":-10.711822,"twenty":-13.208852,"median":-10.056636,"eighty":-6.723204,"marketCap":313212999.52},{"date":"2024-10-11","current":-10.8965,"twenty":-13.208852,"median":-10.066268,"eighty":-6.825982,"marketCap":313104876.9},{"date":"2024-10-18","current":-10.215469,"twenty":-13.208852,"median":-10.066358,"eighty":-6.879142,"marketCap":292591090.92},{"date":"2024-10-25","current":-10.045211,"twenty":-13.208852,"median":-10.066358,"eighty":-6.961026,"marketCap":284585166.47},{"date":"2024-10-31","current":-9.704695,"twenty":-13.208852,"median":-10.066358,"eighty":-7.026961,"marketCap":271944263.97},{"date":"2024-11-08","current":-9.874953,"twenty":-13.208852,"median":-10.082151,"eighty":-7.060172,"marketCap":281291461.06},{"date":"2024-11-15","current":-11.237016,"twenty":-13.208852,"median":-10.148532,"eighty":-7.126596,"marketCap":311309027.17},{"date":"2024-11-22","current":-10.385727,"twenty":-13.208852,"median":-10.199725,"eighty":-7.15201,"marketCap":288886626.95},{"date":"2024-11-29","current":-11.066758,"twenty":-13.208852,"median":-10.215469,"eighty":-7.214464,"marketCap":307229836.23},{"date":"2024-12-06","current":-11.237016,"twenty":-13.208852,"median":-10.21884,"eighty":-7.258757,"marketCap":309083959.43},{"date":"2024-12-13","current":-12.42882,"twenty":-13.208852,"median":-10.223779,"eighty":-7.26106,"marketCap":338876149.23},{"date":"2024-12-20","current":-11.577531,"twenty":-13.208852,"median":-10.280337,"eighty":-7.370498,"marketCap":309579384.66},{"date":"2024-12-27","current":-11.747789,"twenty":-13.208852,"median":-10.280337,"eighty":-7.398331,"marketCap":312274988.18},{"date":"2025-01-03","current":-12.258563,"twenty":-13.208852,"median":-10.280337,"eighty":-7.468322,"marketCap":324781010.98},{"date":"2025-01-10","current":-11.066758,"twenty":-13.212552,"median":-10.320538,"eighty":-7.506988,"marketCap":292642409.93},{"date":"2025-01-17","current":-11.074532,"twenty":-13.212552,"median":-10.37601,"eighty":-7.523726,"marketCap":294232249.66},{"date":"2025-01-24","current":-11.244909,"twenty":-13.212552,"median":-10.381044,"eighty":-7.566148,"marketCap":301591359.95},{"date":"2025-01-31","current":-11.756041,"twenty":-13.212552,"median":-10.385727,"eighty":-7.641687,"marketCap":313059287.45},{"date":"2025-02-07","current":-11.415286,"twenty":-13.212552,"median":-10.391079,"eighty":-7.664453,"marketCap":306449539.34},{"date":"2025-02-14","current":-11.074532,"twenty":-13.212552,"median":-10.425668,"eighty":-7.711893,"marketCap":298069819.8},{"date":"2025-02-21","current":-10.393022,"twenty":-13.212552,"median":-10.429328,"eighty":-7.711893,"marketCap":283804142.43},{"date":"2025-02-28","current":-10.28665,"twenty":-13.212552,"median":-10.429328,"eighty":-7.711893,"marketCap":282126277.35},{"date":"2025-03-07","current":-9.291168,"twenty":-13.216252,"median":-10.429328,"eighty":-7.700033,"marketCap":259347808.46},{"date":"2025-03-14","current":-9.457081,"twenty":-13.216252,"median":-10.429328,"eighty":-7.77924,"marketCap":260973218.42},{"date":"2025-03-21","current":-10.28665,"twenty":-13.216252,"median":-10.429328,"eighty":-7.77997,"marketCap":284026416.57},{"date":"2025-03-28","current":-9.622995,"twenty":-13.216252,"median":-10.429328,"eighty":-7.77997,"marketCap":266339186.07},{"date":"2025-04-04","current":-8.461599,"twenty":-13.216252,"median":-10.429328,"eighty":-7.78862,"marketCap":235981525.21},{"date":"2025-04-11","current":-7.963858,"twenty":-13.212552,"median":-10.429328,"eighty":-7.881984,"marketCap":217117152.27},{"date":"2025-04-17","current":-7.797944,"twenty":-13.212552,"median":-10.429328,"eighty":-7.896491,"marketCap":218236283.02},{"date":"2025-04-25","current":-8.323041,"twenty":-13.216252,"median":-10.429328,"eighty":-7.915718,"marketCap":233542757.63},{"date":"2025-05-02","current":-8.988885,"twenty":-13.216252,"median":-10.429328,"eighty":-7.942501,"marketCap":251855636.82},{"date":"2025-05-09","current":-9.821189,"twenty":-13.216252,"median":-10.429328,"eighty":-8.025194,"marketCap":276411474.4},{"date":"2025-05-16","current":-10.15411,"twenty":-13.216252,"median":-10.429328,"eighty":-8.052196,"marketCap":284831065.35},{"date":"2025-05-23","current":-9.821189,"twenty":-13.216252,"median":-10.429328,"eighty":-8.052951,"marketCap":276358280.84},{"date":"2025-05-30","current":-9.488267,"twenty":-13.216252,"median":-10.429328,"eighty":-8.145857,"marketCap":268229057.16},{"date":"2025-06-06","current":-8.988885,"twenty":-13.216252,"median":-10.429328,"eighty":-8.189442,"marketCap":257245031.97},{"date":"2025-06-13","current":-8.489502,"twenty":-13.216252,"median":-10.429328,"eighty":-8.194472,"marketCap":242826904.67},{"date":"2025-06-20","current":-7.823659,"twenty":-13.219952,"median":-10.429328,"eighty":-8.194472,"marketCap":221485350.11},{"date":"2025-06-27","current":-7.99012,"twenty":-13.219952,"median":-10.429328,"eighty":-8.194472,"marketCap":229395574.32},{"date":"2025-07-03","current":-8.323041,"twenty":-13.219952,"median":-10.429328,"eighty":-8.222992,"marketCap":239911547.51},{"date":"2025-07-11","current":-7.99012,"twenty":-13.219952,"median":-10.429328,"eighty":-8.298135,"marketCap":230042988.97},{"date":"2025-07-18","current":-8.655963,"twenty":-13.219952,"median":-10.429328,"eighty":-8.323041,"marketCap":246159668.72},{"date":"2025-07-25","current":-8.655963,"twenty":-13.219952,"median":-10.429328,"eighty":-8.323041,"marketCap":250843158.49},{"date":"2025-08-01","current":-8.70027,"twenty":-13.219952,"median":-10.429328,"eighty":-8.32398,"marketCap":245414984.89},{"date":"2025-08-08","current":-9.034896,"twenty":-13.219952,"median":-10.429328,"eighty":-8.332736,"marketCap":257587086.31},{"date":"2025-08-15","current":-8.867583,"twenty":-13.219952,"median":-10.429328,"eighty":-8.449827,"marketCap":252554322.17},{"date":"2025-08-22","current":-8.532957,"twenty":-13.219952,"median":-10.429328,"eighty":-8.460439,"marketCap":240386307.24},{"date":"2025-08-29","current":-7.863705,"twenty":-13.219952,"median":-10.429328,"eighty":-8.460439,"marketCap":225088563.78},{"date":"2025-09-05","current":-5.614925,"twenty":-13.223652,"median":-10.429328,"eighty":-8.460671,"marketCap":224444156.42},{"date":"2025-09-12","current":-5.495458,"twenty":-13.219952,"median":-10.429328,"eighty":-8.460439,"marketCap":224638299.29},{"date":"2025-09-19","current":-5.973324,"twenty":-13.219952,"median":-10.429328,"eighty":-8.460439,"marketCap":242798858.67},{"date":"2025-09-26","current":-6.092791,"twenty":-13.219952,"median":-10.429328,"eighty":-8.365644,"marketCap":245044529.62},{"date":"2025-10-03","current":-6.570657,"twenty":-13.219952,"median":-10.429328,"eighty":-8.328654,"marketCap":265794966.09},{"date":"2025-10-10","current":-7.287456,"twenty":-13.219952,"median":-10.429328,"eighty":-8.32398,"marketCap":293342129.47},{"date":"2025-10-17","current":-7.30759,"twenty":-13.219952,"median":-10.429328,"eighty":-8.323041,"marketCap":291781946.57},{"date":"2025-10-24","current":-7.30759,"twenty":-13.219952,"median":-10.429328,"eighty":-8.308097,"marketCap":292294877.92},{"date":"2025-10-31","current":-6.708607,"twenty":-13.219952,"median":-10.429328,"eighty":-8.198331,"marketCap":270094825.35},{"date":"2025-11-07","current":-6.109625,"twenty":-13.219952,"median":-10.429328,"eighty":-8.194472,"marketCap":242639915.96},{"date":"2025-11-14","current":-6.588811,"twenty":-13.219952,"median":-10.425668,"eighty":-8.189442,"marketCap":265306477.03},{"date":"2025-11-21","current":-6.229421,"twenty":-13.219952,"median":-10.393022,"eighty":-8.156581,"marketCap":247541582.79},{"date":"2025-11-28","current":-7.30759,"twenty":-13.219952,"median":-10.391079,"eighty":-8.140496,"marketCap":293268685},{"date":"2025-12-05","current":-6.229421,"twenty":-13.219952,"median":-10.391079,"eighty":-8.052951,"marketCap":253342570.5},{"date":"2025-12-12","current":-8.995735,"twenty":-13.208852,"median":-10.381044,"eighty":-8.052951,"marketCap":368381208.51},{"date":"2025-12-19","current":-9.475508,"twenty":-13.139198,"median":-10.37601,"eighty":-8.052951,"marketCap":385509877.48},{"date":"2025-12-26","current":-9.95528,"twenty":-13.077705,"median":-10.36381,"eighty":-8.052951,"marketCap":409805910.61},{"date":"2026-01-02","current":-10.31511,"twenty":-13.013979,"median":-10.320538,"eighty":-8.052951,"marketCap":422833229.47},{"date":"2026-01-09","current":-10.435053,"twenty":-12.98835,"median":-10.31511,"eighty":-8.052951,"marketCap":428837225.23},{"date":"2026-01-16","current":-10.554996,"twenty":-12.915322,"median":-10.31511,"eighty":-8.052951,"marketCap":435076069.51},{"date":"2026-01-23","current":-11.034769,"twenty":-12.843543,"median":-10.28665,"eighty":-8.052951,"marketCap":463339347.96},{"date":"2026-01-30","current":-9.475508,"twenty":-12.814101,"median":-10.280337,"eighty":-8.052951,"marketCap":407333227.21},{"date":"2026-02-06","current":-8.755849,"twenty":-12.726034,"median":-10.280337,"eighty":-8.052951,"marketCap":374666208.82}],"updateTime":1770474211038},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMMP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609967605","title":"Immutep Hits 50% Enrollment in Late-Stage Lung Cancer Trial Combining Efti With Keytruda and Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2609967605","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609967605?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:33","pubTimestamp":1770384785,"startTime":"0","endTime":"0","summary":"Immutep  said Friday that it has enrolled half of the target patients in a late-stage study testing its experimental cancer drug with Merck's Keytruda and chemotherapy for advanced lung cancer.The late-stage trial is studying eftilagimod alfa, or efti, as a first-line treatment for people with advanced or metastatic non-small cell lung cancer, the company said. So far, 378 patients have been enrolled across more than 140 clinical sites in 27 countries, the company said.The company said it expects to complete a futility analysis in Q1 and finish patient enrollment in Q3.The study aims to determine whether adding efti to Keytruda and chemotherapy improves survival and delays disease progression compared with standard treatment alone, Immutep said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1989771016.USD","LU2468319806.SGD","BK4139","IE00B1BXHZ80.USD","LU2361044949.HKD","SG9999014542.SGD","IE00BN8TJ469.HKD","LU2324357040.USD","LU1983299246.USD","LU0130517989.USD","LU0965508806.USD","LU2023250843.SGD","LU1291159041.SGD","LU0203345920.USD","LU2112291526.USD","BK4007","LU0965509101.SGD","BK4533","LU0211331839.USD","LU1929549753.HKD","LU2461242641.AUD","LU1430594728.SGD","LU0265550359.USD","LU1941712264.USD","LU2360032135.SGD","IE0002141913.USD","LU1066051498.USD","LU0266013472.USD","LU1069347547.HKD","LU1989772840.SGD","LU1934455863.HKD","LU1571399168.USD","LU0980610538.SGD","LU0320765489.SGD","LU0238689110.USD","LU0130102774.USD","LU1066051225.USD","LU1116320737.USD","LU0861579265.USD","LU0203347892.USD","LU1037948897.HKD","LU2125154935.USD","LU1066053197.SGD","LU0070302665.USD","SG9999014575.USD","LU0289739699.SGD","LU1699723380.USD","LU1989772923.USD","LU0965509283.SGD","LU1941712348.USD","LU2023250504.SGD","LU1093756325.SGD","LU0234572021.USD","LU0265550946.USD","LU1037948541.HKD","SG9999001176.USD","IE00BJJMRZ35.SGD","IE00BLSP4239.USD","LU1093756168.USD","SG9999002232.USD","SG9999014559.SGD","IE00B2B36J28.USD","BK4585","LU1974910355.USD","LU1162221912.USD","LU2125154778.USD","LU1116320901.HKD","LU2089984988.USD","BK4534","IE00BJT1NW94.SGD","LU1023059063.AUD","BK4516","LU1934455194.USD","LU1061106388.HKD","BK4588","LU0985320562.USD","IE000M9KFDE8.USD","SG9999014567.USD","SG9999015358.SGD","SG9999015341.SGD","IE00BLSP4452.SGD","LU0208291251.USD","BK4559","LU0122379950.USD","SG9999002224.SGD","LU2361045086.USD","LU0320765646.SGD","SG9999001440.SGD","SGXZ57979304.SGD","LU1934455277.USD","SG9999001176.SGD","LU2361044865.SGD","LU1066051811.HKD","IE00BBT3K403.USD","LU1035773651.USD","LU0477156953.USD","IE0009355771.USD","LU2106854487.HKD","LU0058720904.USD","LU0648001328.SGD","IE00B4R5TH58.HKD","LU0098860793.USD","LU1201861249.SGD","IE00BSNM7G36.USD","LU1057294990.SGD","LU1917777945.USD","LU1585245621.USD","IMMP","LU0106261372.USD","BK4550","SG9999013999.USD","LU0965509010.AUD","LU0006306889.USD","IE00BFTCPJ56.SGD","LU0432979614.USD"],"gpt_icon":0},{"id":"2609969025","title":"Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2609969025","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609969025?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:00","pubTimestamp":1770382800,"startTime":"0","endTime":"0","summary":"The registrational TACTI-004 trial in first line non-small cell lung cancer (1L NSCLC) has enrolled 378 patients globally, 50% of the trial's targeted enrolment Futility analysis and completion of pat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/06/3233774/0/en/Immutep-Achieves-50-Enrolment-in-Global-TACTI-004-KEYNOTE-F91-Phase-III-Trial-in-1L-NSCLC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","BK4134","BK4139","IMMP"],"gpt_icon":0},{"id":"2607080673","title":"Immutep reports Q2 cash receipts from customers A$4,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2607080673","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607080673?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:21","pubTimestamp":1769692880,"startTime":"0","endTime":"0","summary":"The company said, “During the quarter, Immutep (IMMP) continued to exercise prudent cash management as it advanced its clinical trial programs for ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immutep-reports-q2-cash-receipts-from-customers-a4000-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immutep-reports-q2-cash-receipts-from-customers-a4000-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMMP","BK4139"],"gpt_icon":0},{"id":"2593323744","title":"Why Wall Street Is Watching Immutep's Experimental Autoimmune Treatment Closely","url":"https://stock-news.laohu8.com/highlight/detail?id=2593323744","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593323744?lang=en_us&edition=fundamental","pubTime":"2025-12-23 01:59","pubTimestamp":1766426340,"startTime":"0","endTime":"0","summary":"Immutep Limited  on Monday shared an update from the placebo-controlled, double-blind first-in-human Phase I study in healthy participants evaluating IMP761, a first-in-class LAG-3 agonist antibody for autoimmune diseases.The single-ascending dose escalation portion of the trial completed the 2.5 and 7 mg/kg dosing levels of IMP761 with continued positive safety and efficacy data.IMP761 was tolerated well with no treatment-related adverse reactions beyond mild intensity.Also Read: Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo. Additionally, evidence of dose-dependent immunosuppressive effects with IMP761 was observed with significant, long-lasting inhibition of the three T-cell-mediated intradermal reactions to a strong foreign antigen at day 2, 9, and 23.Dr. Frédéric Triebel, CSO of Immutep, said: “We are excited to see IMP761 having a long-term immunosuppressive effect after a single injection…Encouragingly, our clinical progress with IMP761 ","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/22/Medical-Research.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/22/Medical-Research.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/25/12/49544366/why-wall-street-is-watching-immuteps-experimental-autoimmune-treatment-closely","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49544366/why-wall-street-is-watching-immuteps-experimental-autoimmune-treatment-closely","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["IMMP","BK4139"],"gpt_icon":0},{"id":"2593348063","title":"Immutep Announces Positive Update on IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases, from Phase I Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2593348063","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593348063?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:00","pubTimestamp":1766408400,"startTime":"0","endTime":"0","summary":"Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive effect against a strong foreign antigen observed with continued favourable sa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/22/3209162/0/en/Immutep-Announces-Positive-Update-on-IMP761-a-First-in-Class-LAG-3-Agonist-Antibody-for-Autoimmune-Diseases-from-Phase-I-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMMP","DTH","BK4139"],"gpt_icon":0},{"id":"2591825989","title":"Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace","url":"https://stock-news.laohu8.com/highlight/detail?id=2591825989","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591825989?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:00","pubTimestamp":1765890000,"startTime":"0","endTime":"0","summary":"The registrational TACTI-004 Phase III has enrolled 289 patients globally, over 38% of the trial’s targeted enrolmentStrong operational progress continues globally with over 120 activated clinical sit","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/16/3206183/0/en/Immutep-Announces-Strong-Operational-Progress-in-Global-TACTI-004-KEYNOTE-F91-Phase-III-and-Enrolment-Continues-at-Robust-Pace.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","PRGS","BK4097","IMMP","BK4139","BK4134","LU2065732104.USD"],"gpt_icon":0},{"id":"2589435540","title":"Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa","url":"https://stock-news.laohu8.com/highlight/detail?id=2589435540","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589435540?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:00","pubTimestamp":1765198800,"startTime":"0","endTime":"0","summary":"Dr. Reddy’s receives exclusive rights to develop and commercialise Eftilagimod Alfa in all countries outside North America, Europe, Japan, and Greater China Under the terms, Immutep to receive upfront","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/08/3201497/0/en/Immutep-and-Dr-Reddy-s-enters-into-Strategic-Collaboration-for-Commercialisation-of-an-Innovative-Oncology-Drug-Eftilagimod-Alfa.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4557","BK4596","IMMP","RDY","BK4523","BK4532","BK4139","LU0348744763.USD"],"gpt_icon":0},{"id":"2588405322","title":"Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2588405322","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588405322?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:00","pubTimestamp":1764680400,"startTime":"0","endTime":"0","summary":"Immunotherapy-chemotherapy combination of eftilagimod alfa (efti) and paclitaxel led to strong objective response rates and immune activation in heavily pretreated metastatic breast cancer patientsAIP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/02/3197884/0/en/Immutep-to-Present-New-Data-from-AIPAC-003-Phase-II-at-the-2025-San-Antonio-Breast-Cancer-Symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMMP","LU0053666078.USD","BK4198","BK4590","ORR","L","ALC","LU1169589451.USD","ET","BK4534","LU1804176565.USD","BK4588","LU1169590202.USD","BK4086","BK4023","BK4107","LU2487616109.SGD","BK4144","BK4585","BK4581","MBC","LU2265009873.SGD","PD","LU0210528500.USD","BK4139","BK4561"],"gpt_icon":0},{"id":"2583596116","title":"Translational Data and Significant Pathologic Response Rates from EFTISARC-NEO Phase II Highlighted in Oral Presentation at CTOS 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2583596116","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583596116?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:00","pubTimestamp":1763038800,"startTime":"0","endTime":"0","summary":"Novel combination with neoadjuvant eftilagimod alfa (efti) achieves significant 51.5% tumour hyalinization/fibrosis across multiple soft tissue sarcoma subtypes including rare and highly aggressive tu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/13/3187275/0/en/Translational-Data-and-Significant-Pathologic-Response-Rates-from-EFTISARC-NEO-Phase-II-Highlighted-in-Oral-Presentation-at-CTOS-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","LU0012050646.USD","LU0106261612.USD","BK4139","BK4121","CTOS","NEO","BK4104","IMMP"],"gpt_icon":0},{"id":"2580954213","title":"Immutep Receives A$4.6 million R&D Tax Incentive from French Government","url":"https://stock-news.laohu8.com/highlight/detail?id=2580954213","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580954213?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:00","pubTimestamp":1762174800,"startTime":"0","endTime":"0","summary":"Media Release SYDNEY, AUSTRALIA, Nov.  03, 2025  (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (\"Immutep“ or “the Company”), a late-stage immunotherapy company targeting cancer and auto","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/03/3179212/0/en/Immutep-Receives-A-4-6-million-R-D-Tax-Incentive-from-French-Government.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMMP","BK4139","CIR","BK4161"],"gpt_icon":0},{"id":"2579903512","title":"Immutep Quarterly Activities Report Q1 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2579903512","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579903512?lang=en_us&edition=fundamental","pubTime":"2025-10-29 20:00","pubTimestamp":1761739200,"startTime":"0","endTime":"0","summary":"Media Release Pivotal TACTI-004 (KEYNOTE-F91) Phase III trial evaluating eftilagimod alfa (efti) in first line non-small cell lung cancer continues to build momentum and is recruiting patients at a gr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/29/3176384/0/en/Immutep-Quarterly-Activities-Report-Q1-FY26.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOS","BK4104","BK4139","NAC","IMMP"],"gpt_icon":0},{"id":"2577927530","title":"Immutep Limited Releases 2025 Corporate Governance Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2577927530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577927530?lang=en_us&edition=fundamental","pubTime":"2025-10-24 06:37","pubTimestamp":1761259056,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Immutep Ltd ( ($AU:IMM) ). Immutep Limited has released its corporate governance statement for the financial ye...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immutep-limited-releases-2025-corporate-governance-statement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immutep-limited-releases-2025-corporate-governance-statement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IMMP"],"gpt_icon":0},{"id":"2576573888","title":"Immutep Says its Mid-Stage Trial of Eftilagimod Alfa Meets Primary Endpoint of Tumor Hyalinization/Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2576573888","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576573888?lang=en_us&edition=fundamental","pubTime":"2025-10-20 21:20","pubTimestamp":1760966401,"startTime":"0","endTime":"0","summary":"Immutep (IMMP) said Monday that its Eftisarc-neo mid-stage study of eftilagimod alfa with radiotherapy plus Keytruda has met its primary endpoint and \"significantly exceeded\" the trial's prespecified ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMMP","SSI","BK4139"],"gpt_icon":0},{"id":"2576519318","title":"Immutep announces Phase II study of eftilagimod alfa met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2576519318","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576519318?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:21","pubTimestamp":1760962910,"startTime":"0","endTime":"0","summary":"Immutep (IMMP) announces positive data from the EFTISARC-NEO Phase II trial were shared in a Proffered Paper oral presentation by Katarzyna Kozak, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immutep-announces-phase-ii-study-of-eftilagimod-alfa-met-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immutep-announces-phase-ii-study-of-eftilagimod-alfa-met-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IMMP"],"gpt_icon":0},{"id":"2576510178","title":"Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576510178","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576510178?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:01","pubTimestamp":1760961660,"startTime":"0","endTime":"0","summary":"Novel combination including eftilagimod alfa (efti) in neoadjuvant setting drives 51.5% tumour hyalinization/fibrosis in patients with soft tissue sarcoma (p<0.001) High level of tumour hyalinization/","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/20/3169335/0/en/Primary-Endpoint-Met-in-EFTISARC-NEO-Phase-II-Evaluating-Neoadjuvant-Efti-in-Soft-Tissue-Sarcoma-and-Data-Presented-at-ESMO-Congress-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU0012050646.USD","NEO","IMMP","LU0106261612.USD","BK4196","BK4139"],"gpt_icon":0},{"id":"2576064851","title":"Two Posters at ESMO Congress 2025 Highlight Immutep’s Focus on Changing Treatment Landscape in First Line Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2576064851","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576064851?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:00","pubTimestamp":1760961600,"startTime":"0","endTime":"0","summary":"Novel combination of efti with KEYTRUDA and chemotherapy generates strong response rates across all PD-L1 expression levels in first line non-small cell lung cancer (1L NSCLC) including 61.7% ORR in l","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/20/3169319/0/en/Two-Posters-at-ESMO-Congress-2025-Highlight-Immutep-s-Focus-on-Changing-Treatment-Landscape-in-First-Line-Non-Small-Cell-Lung-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","LU1430594728.SGD","LU1069347547.HKD","LU1941712264.USD","LU2324357040.USD","SG9999013999.USD","INAQU","SG9999014567.USD","BK4007","ORR","LU0208291251.USD","BK4533","IE00BSNM7G36.USD","LU0211331839.USD","LU0965509101.SGD","LU1023059063.AUD","LU2487616109.SGD","LU2461242641.AUD","LU1037948897.HKD","LU0122379950.USD","IMMP","IE00BFTCPJ56.SGD","LU1057294990.SGD","MRK","LU1974910355.USD","IE00BN8TJ469.HKD","LU2361044949.HKD","LU0265550359.USD","LU1116320901.HKD","LU1035773651.USD","SG9999001440.SGD","BK4516","LU0965508806.USD","L","SG9999014542.SGD","LU0070302665.USD","BK4559","LU0320765646.SGD","LU0238689110.USD","LU2361045086.USD","LU1066051811.HKD","LU0265550946.USD","LU1941712348.USD","LU0985320562.USD","IE000M9KFDE8.USD","LU1162221912.USD","SG9999014559.SGD","LU0058720904.USD","LU2106854487.HKD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2574152926","title":"Immutep announces update for TACTI-004 Phase III trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2574152926","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574152926?lang=en_us&edition=fundamental","pubTime":"2025-10-09 20:16","pubTimestamp":1760012166,"startTime":"0","endTime":"0","summary":"Immutep (IMMP) announces a patient enrolment update for the TACTI-004 Phase III trial evaluating eftilagimod alfa in combination with MSD’s (MRK) a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immutep-announces-update-for-tacti-004-phase-iii-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immutep-announces-update-for-tacti-004-phase-iii-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1061106388.HKD","LU1983299246.USD","LU1989772923.USD","BK4134","LU1093756325.SGD","LU0122379950.USD","IMMP","LU0106261372.USD","LU0320765489.SGD","LU1162221912.USD","LU1934455863.HKD","SG9999001176.USD","BK4533","LU1057294990.SGD","LU0058720904.USD","LU0985320562.USD","III","IE00B2B36J28.USD","IE00BLSP4239.USD","LU1917777945.USD","LU0098860793.USD","IE00BN8TJ469.HKD","LU1941712264.USD","IE000M9KFDE8.USD","LU1430594728.SGD","LU1066053197.SGD","LU1974910355.USD","LU2023250504.SGD","SG9999015358.SGD","LU0234572021.USD","LU2361044865.SGD","BK4559","IE00BBT3K403.USD","LU1037948541.HKD","IE00BFTCPJ56.SGD","LU0070302665.USD","LU1934455277.USD","IE00BLSP4452.SGD","IE00B1BXHZ80.USD","SG9999014567.USD","LU2361044949.HKD","MRK","BK4534","LU1291159041.SGD","LU0320765646.SGD","LU1066051811.HKD","BK4007","LU1116320901.HKD","LU1989772840.SGD","LU0208291251.USD"],"gpt_icon":0},{"id":"2569778268","title":"Immutep Announces Research Collaboration with the George Washington University Cancer Center to Evaluate Neoadjuvant Efti","url":"https://stock-news.laohu8.com/highlight/detail?id=2569778268","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569778268?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:00","pubTimestamp":1758542400,"startTime":"0","endTime":"0","summary":"GW Cancer Center to initiate Phase II trial evaluating neoadjuvant efti as monotherapy and in combination with chemotherapy prior to surgery in HR+/HER2-neg breast cancer patientsSecond investigator-i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/22/3153886/0/en/Immutep-Announces-Research-Collaboration-with-the-George-Washington-University-Cancer-Center-to-Evaluate-Neoadjuvant-Efti.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","BK4139","LU1066051498.USD","LU2236285917.USD","APC","LU0882574139.USD","LU1674673691.USD","LU1066051811.HKD","LU1066053197.SGD","LU1935042215.USD","LU0149725797.USD","IMMP","LU2456880835.USD","BK4211","LU1935043536.SGD","LU2420271590.USD","LU1066051225.USD","LU2237443549.SGD","LU2083900584.USD","LU1778281490.HKD","LU0314104364.USD","LU1718418525.SGD","LU1496350171.SGD","LU0170899867.USD","LU1935042991.SGD","LU1366192091.USD","LU1366333091.USD","NAC","WASH","LU1935042488.USD","LU2237443382.USD","LU2237443622.USD","LU1935043023.USD","BK4141","LU2237443978.SGD","LU0157215616.USD","LU0786609619.USD","LU1674673428.USD","LU2417539215.USD","LU0077335932.USD","MMAT"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}